BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21801148)

  • 1. Nanotechnology platforms; an innovative approach to brain tumor therapy.
    Nair BG; Varghese SH; Nair R; Yoshida Y; Maekawa T; Kumar DS
    Med Chem; 2011 Sep; 7(5):488-503. PubMed ID: 21801148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain cancer diagnosis and therapy with nanoplatforms.
    Koo YE; Reddy GR; Bhojani M; Schneider R; Philbert MA; Rehemtulla A; Ross BD; Kopelman R
    Adv Drug Deliv Rev; 2006 Dec; 58(14):1556-77. PubMed ID: 17107738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
    Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
    Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on Dual Targeting Delivery Systems for Brain Tumors.
    Gao H
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):6-16. PubMed ID: 27270720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier.
    Caraglia M; De Rosa G; Salzano G; Santini D; Lamberti M; Sperlongano P; Lombardi A; Abbruzzese A; Addeo R
    Curr Cancer Drug Targets; 2012 Mar; 12(3):186-96. PubMed ID: 22268384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy.
    Aparicio-Blanco J; Sanz-Arriazu L; Lorenzoni R; Blanco-Prieto MJ
    Int J Pharm; 2020 May; 581():119283. PubMed ID: 32240807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive nanoparticle strategies for brain tumor targeting.
    Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
    Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patented nanomedicines for the treatment of brain tumors.
    Caruso G; Raudino G; Caffo M
    Pharm Pat Anal; 2013 Nov; 2(6):745-54. PubMed ID: 24237240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanobiotechnology-based delivery strategies: New frontiers in brain tumor targeted therapies.
    Mangraviti A; Gullotti D; Tyler B; Brem H
    J Control Release; 2016 Oct; 240():443-453. PubMed ID: 27016141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment.
    Ganipineni LP; Danhier F; Préat V
    J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.
    Garg T; Bhandari S; Rath G; Goyal AK
    J Drug Target; 2015 Dec; 23(10):865-87. PubMed ID: 25835469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Precise are Nanomedicines in Overcoming the Blood-Brain Barrier? A Comprehensive Review of the Literature.
    Mohapatra P; Gopikrishnan M; Doss C GP; Chandrasekaran N
    Int J Nanomedicine; 2024; 19():2441-2467. PubMed ID: 38482521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Nanomedicine to Brain Tumors: Latest Progress and Achievements.
    Van't Root M; Lowik C; Mezzanotte L
    Curr Pharm Des; 2017; 23(13):1953-1962. PubMed ID: 28025944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in brain tumor-targeted nano-drug delivery systems.
    Liu Y; Lu W
    Expert Opin Drug Deliv; 2012 Jun; 9(6):671-86. PubMed ID: 22607535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine for the treatment of Alzheimer's disease.
    Gregori M; Masserini M; Mancini S
    Nanomedicine (Lond); 2015; 10(7):1203-18. PubMed ID: 25929574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique roles of nanotechnology in medicine and cancer.
    Alam F; Naim M; Aziz M; Yadav N
    Indian J Cancer; 2014; 51(4):506-10. PubMed ID: 26842179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
    Tam VH; Sosa C; Liu R; Yao N; Priestley RD
    Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
    Meng J; Agrahari V; Youm I
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.